Starpharma Holdings Ltd. (OTCMKTS:SPHRY – Get Free Report)’s share price dropped 7.1% on Friday. The stock traded as low as $3.02 and last traded at $3.25. 1,100 shares were traded during mid-day trading, an increase of 43% from the average daily volume of 768 shares. The stock had previously closed at $3.50.
Starpharma Stock Down 7.1%
The company’s fifty day moving average is $5.08 and its 200 day moving average is $4.37.
Starpharma Company Profile
Starpharma is an Australian biotechnology company focused on developing pharmaceutical products and medical applications based on its proprietary dendrimer technology. Dendrimers are highly branched, nanoscale polymers that can be engineered to deliver active ingredients or provide antiviral and antimicrobial effects.
The company’s best-known product is VivaGel BV, a vaginal gel containing astodrimer sodium that is designed to treat and help prevent the recurrence of bacterial vaginosis.
Featured Stories
- Five stocks we like better than Starpharma
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
